News
Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...
Yelp Inc. YELP) on Thursday reported second-quarter profit of $44.1 million. On a per-share basis, the San Francisco-based company said it had net income of 67 cents.
Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug ...
MBIA Inc. MBI) on Wednesday reported a loss of $56 million in its second quarter. On a per-share basis, the Purchase, New ...
Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, ...
Shares of Hims & Hers tumbled 12% in after-hours trading Monday after the company's second-quarter revenue missed Wall Street ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
NVO's second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, ...
6d
Zacks Investment Research on MSNShould You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate ...
9d
Zacks Investment Research on MSNRegeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales UpRegeneron Pharmaceuticals, Inc. (REGN) reported second-quarter 2025 adjusted earnings per share (EPS) of $12.89, which ...
Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...
Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results